IL161066A0 - Method for preparing heparin from mast cell cultures - Google Patents

Method for preparing heparin from mast cell cultures

Info

Publication number
IL161066A0
IL161066A0 IL16106602A IL16106602A IL161066A0 IL 161066 A0 IL161066 A0 IL 161066A0 IL 16106602 A IL16106602 A IL 16106602A IL 16106602 A IL16106602 A IL 16106602A IL 161066 A0 IL161066 A0 IL 161066A0
Authority
IL
Israel
Prior art keywords
cell cultures
mast cell
preparing heparin
heparin
preparing
Prior art date
Application number
IL16106602A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL161066A0 publication Critical patent/IL161066A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16106602A 2001-10-22 2002-10-22 Method for preparing heparin from mast cell cultures IL161066A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113606A FR2831186B1 (fr) 2001-10-22 2001-10-22 Production d'heparine a partir de cultures de mastocytes
PCT/FR2002/003617 WO2003035886A2 (fr) 2001-10-22 2002-10-22 Preparation d'heparine a partir de cultures de mastocytes

Publications (1)

Publication Number Publication Date
IL161066A0 true IL161066A0 (en) 2004-08-31

Family

ID=8868558

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16106602A IL161066A0 (en) 2001-10-22 2002-10-22 Method for preparing heparin from mast cell cultures

Country Status (18)

Country Link
US (1) US20050042733A1 (fr)
EP (1) EP1438415A2 (fr)
JP (1) JP2005506092A (fr)
KR (1) KR20040071127A (fr)
CN (1) CN1575341A (fr)
AR (1) AR036915A1 (fr)
BR (1) BR0213478A (fr)
CA (1) CA2462714A1 (fr)
CO (1) CO5570711A2 (fr)
FR (1) FR2831186B1 (fr)
HU (1) HUP0401794A2 (fr)
IL (1) IL161066A0 (fr)
MX (1) MXPA04003740A (fr)
NO (1) NO20041633L (fr)
NZ (1) NZ532414A (fr)
PL (1) PL368599A1 (fr)
WO (1) WO2003035886A2 (fr)
ZA (1) ZA200402304B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2853663B1 (fr) * 2003-04-14 2007-08-31 Aventis Pharma Sa Procede d'obtention de lignees de mastocytes a partir de tissus de porcs et procede de production de molecules de type heparine
FR2876386B1 (fr) * 2004-10-12 2007-04-06 Aventis Pharma Sa Lignees de mastocytes porcins produisant des molecules de type heparine
KR100688553B1 (ko) * 2005-06-22 2007-03-02 삼성전자주식회사 코어 사이즈를 감소시킨 반도체 메모리 장치
KR101447123B1 (ko) * 2014-02-27 2014-10-06 박상협 헤파린의 추출 방법
KR102104367B1 (ko) 2019-09-02 2020-04-24 팜앤바이오 주식회사 헤파린나트륨의 제조장치 및 제조방법
CN111979193A (zh) * 2019-09-27 2020-11-24 云南洛宇生物科技有限公司 大鼠骨髓源肥大细胞培养方法
CN110592165B (zh) * 2019-10-18 2021-04-27 福州大学 燕窝中硫酸乙酰肝素/肝素的提取方法与结构解析

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016331A (en) * 1960-01-28 1962-01-09 Ormonoterapia Richter Spa Purification of heparin
AU5810690A (en) * 1989-05-19 1990-12-18 University Of Alabama, The Heparin-producing murine mastocytoma cell lines
JP3507852B2 (ja) * 1993-12-10 2004-03-15 ジェネンテク，インコーポレイテッド アレルギー診断法および抗アレルギー性治療剤のスクリーニング法
FI974321A0 (fi) * 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
US6596705B1 (en) * 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin

Also Published As

Publication number Publication date
NZ532414A (en) 2006-12-22
KR20040071127A (ko) 2004-08-11
ZA200402304B (en) 2004-10-07
CA2462714A1 (fr) 2003-05-01
FR2831186A1 (fr) 2003-04-25
NO20041633L (no) 2004-04-21
PL368599A1 (en) 2005-04-04
BR0213478A (pt) 2004-11-03
MXPA04003740A (es) 2005-06-20
FR2831186B1 (fr) 2004-06-18
CO5570711A2 (es) 2005-10-31
WO2003035886A3 (fr) 2004-02-26
EP1438415A2 (fr) 2004-07-21
US20050042733A1 (en) 2005-02-24
HUP0401794A2 (hu) 2004-11-29
JP2005506092A (ja) 2005-03-03
AR036915A1 (es) 2004-10-13
CN1575341A (zh) 2005-02-02
WO2003035886A2 (fr) 2003-05-01

Similar Documents

Publication Publication Date Title
IL161858A0 (en) Cell culture process
EP1445022A3 (fr) Trous d accès de plaque de filtre multipuits pour appareil d essai
IL143421A0 (en) Method for culturing algae
AU2002357049A1 (en) Methods for preparing 0-desmethylvenlafaxine
HK1069578A1 (en) Method for preparing benzenesulfonyl compounds
HUP0400129A3 (en) Method for producing isocyanates
IL161066A0 (en) Method for preparing heparin from mast cell cultures
EP1245548A4 (fr) Procede de fabrication de vitroceramique
EP1298117A3 (fr) Procédé de préparation de bromofluorènes
PL373093A1 (en) Method for introducing insulation elements
EP1229116A4 (fr) Procede de preparation de fractions cellulaires contenant des hemangioblastes
AU2002358848B2 (en) Method for preparing heparin from mast cell cultures
AU2002358848A1 (en) Method for preparing heparin from mast cell cultures
AU4663601A (en) Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin derivativesfrom 9-deoxo-9(z)-hydroxyiminoerythromycin
GC0000387A (en) Electrolytic cell regulation method
GB0218570D0 (en) Daughter-card structural support
HUP0401401A3 (en) Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
AU2002241271A1 (en) Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
HUP0204443A3 (en) Process for preparing fluoroformates
HUP0500331A3 (en) Method for producing isocyanates
GC0000388A (en) Electrolytic cell regulation method
AUPR909801A0 (en) A method for culturing cells
EP1334093A4 (fr) Procede de preparation de dl-alpha-tocopherol avec un haut rendement
GB0103611D0 (en) Further improved method for detecting cells
AU2002351650A8 (en) Support method